Stay updated on Sorafenib with or without SBRT in Liver Cancer Clinical Trial
Sign up to get notified when there's something new on the Sorafenib with or without SBRT in Liver Cancer Clinical Trial page.

Latest updates to the Sorafenib with or without SBRT in Liver Cancer Clinical Trial page
- Check7 days agoChange DetectedAdded Revision: v3.5.2 and removed Revision: v3.5.0.SummaryDifference0.0%

- Check14 days agoNo Change Detected
- Check21 days agoChange Detected- Added the term 'Adult hepatocellular carcinoma' to the conditions list and removed 'Hepatocellular carcinoma' from the list.SummaryDifference0.0%

- Check36 days agoChange DetectedAdded MeSH term Hepatocellular carcinoma and a Genetic and Rare Diseases Information Center resource; updated the page revision from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check43 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3. No user-facing content or functionality changes are indicated.SummaryDifference0.0%

- Check72 days agoChange DetectedRevision: v3.4.2 was added and the prior government funding/operating status notice was removed; these site maintenance changes do not affect the study information, and to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check79 days agoChange DetectedUpdated study plan sections add NIH-required analyses and core outcome definitions (overall survival by race/ethnicity/sex, time to progression, progression-free survival) and the follow-up schedule. A funding lapse notice and revised dates (2026-01-08, 2026-01-28) are now displayed.SummaryDifference0.8%

Stay in the know with updates to Sorafenib with or without SBRT in Liver Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Sorafenib with or without SBRT in Liver Cancer Clinical Trial page.